Le Lézard
Classified in: Health
Subjects: NPT, AVO, MAT

ASTHO Commends the Surgeon General Advisory About Marijuana Use on the Developing Brain


ARLINGTON, Va., Aug. 29, 2019 /PRNewswire/ -- Michael Fraser, Chief Executive Officer of the Association of State and Territorial Health Officials (ASTHO), issued the following statement in response to the Surgeon General's advisory on marijuana use and its impact on the developing brain:

ASTHO Logo (PRNewsfoto/Association of State and Territ)

"State and territorial public health officials commend the Surgeon General's announcement today. We strongly encourage pregnant and breastfeeding women, parents, and youth to learn more about the risks associated with marijuana products by consulting with their health care provider. ASTHO supports the Surgeon General's request for additional research on the health impacts of marijuana use. A strong evidence base rooted in science will allow state and territorial health agencies to effectively fulfill their responsibility to promote and protect the public's health. We also strongly encourage increased investments in substance abuse and misuse prevention programs, public awareness initiatives, and health care provider education programs centered on marijuana use."

ASTHO is the national nonprofit organization representing the public health agencies of the United States, the U.S. territories and freely associated states, and the District of Columbia, as well as the more than 100,000 public health professionals these agencies employ. ASTHO members, the chief health officials of these jurisdictions, are dedicated to formulating and influencing sound public health policy and to ensuring excellence in public health practice.

 

SOURCE Association of State and Territorial Health Officials


These press releases may also interest you

at 03:47
Zest Dental Solutions, a global leader in innovative dental solutions proudly announces a strategic partnership with The Pathway. Founded by Justin Moody, DDS and based in Arizona, The Pathway is a continuing education program that teaches dentists...

at 03:34
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that its selective cathepsin K inhibitor, MIV-711, has been granted Rare Pediatric Disease...

at 03:16
First quarter Net sales reached SEK 9.4 (13.0) million.The operating result totaled SEK -18.4 (-14.4) million.Earnings per share, basic and diluted, were SEK -0.11 (-0.09).Cash flow from operating activities totaled SEK -7.3 (-12.2) million.CEO...

at 03:03
International medical imaging IT and cybersecurity company Sectra (STO: SECT B) will provide its platform for medical education, Sectra Education Portal, to four university colleges in Denmark. With the solution, they aim to elevate the educational...

at 03:00
Sentrycs, a leading innovator in adaptive counter-drone solutions, is proud to announce its inclusion in the prestigious UK National Protective Security Authority Catalogue of Security Equipment (NPSA CSE).  ...

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...



News published on and distributed by: